Global Wearable Cardioverter Defibrillator Market Outlook 2028

  • Product Code:
    RP-ID-10346753
  • Published Date:
    8 Jan 2021
  • Region:
    Global
  • Pages:
    553
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-9

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global Wearable Cardioverter Defibrillators Market Analysis 2019-2028
Wearable cardioverter defibrillators are wearable devices which are capable of administering electrical shock to the heart for preventing sudden cardiac death (SDC). The major cause of death is cardiovascular disorder, as a result of which, a significant number of new manufacturers are interested to invest in new technologies for providing advanced screening and treatment options. An external defibrillator is attached in the wearable cardioverter defibrillator to a vest that is worn by the patient. It is highly used in patients to bridge the situation where the patient is looking for an Implantable Cardioverter Defibrillator (ICD). The value of global wearable cardioverter defibrillator market is expected to reach around USD 1100 million by 2028, by registering a CAGR of 25.45% across the globe during the forecast period, i.e. 2021-2028. The increasing investment in various international healthcare programs funded by the government and other organizations such as the World Health Organization, increasing old age population, changes in disease prevalence or incidence rate, and increasing cost of services, are the major factors accelerating the market growth.
The global wearable cardioverter defibrillator market consists of various segments that are segmented by indication, demography, end user, and by region. The market is further segmented by demography into pediatric, adults, and geriatric. Out of these, the adult segment recorded the highest share, as the adult population in the world has increased rapidly over the past few years. People with high-risk of cardiovascular diseases usually include adults with hypertension, diabetes, obesity, and other factors. Adults segment is estimated to touch around USD 150,000 thousand in 2020. Moreover, the increasing geriatric population across the world is expected to raise demand for wearable cardioverter defibrillator to monitor and manage cardiovascular diseases. Among pediatric patients, congenital heart disease is the most common heart defect. Although cardiovascular disorders are a great concern in adult population, the increasing prevalence of childhood obesity has increased the risk of cardiovascular complications in children, which in turn is anticipated to drive the growth of the wearable cardioverter defibrillators market.
Based on region, the global wearable cardioverter defibrillators market is segmented into five major regions including North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Among these regions, the market in North America had registered the largest share of around 47% in the year 2019 and is expected to grow significantly over the years on the back of increasing investment towards the medical device sector from government and private organizations to maintain the highest quality of services. Owing to various innovations in devices and tools used, there has been a rise in demand for efficient resources across the medical devices sector. Moreover, the Europe wearable cardioverter defibrillators market is expected to reach a market size of around USD 320,000 thousand by 2028 owing to the increasing demand for advanced medical devices owing to the changing medical practices and the rise of new manufacturing technologies.
Some of the prominent industry leaders in the global wearable cardioverter defibrillators market are ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation, and General Electric Company.
Wearable Cardioverter Defibrillator Market

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Product Overview
2. Assumptions And Acronyms
3. Research Methodology
4. Analyst Review
5. Executive Summary - Global Wearable Cardioverter Defibrillator Market
6. Regulatory & Standards Landscape
7. Analysis Of Market Dynamics
7.1. Growth Drivers
7.2. Market Trends
8. Major Roadblocks For The Market Growth
9. Risk Analysis
10. Impact Of Covid-19 On The Wearable Cardioverter Defibrillator Market
11. Key Market Opportunities
12. Epidemiology Analysis
13. Analysis Of Wearable Cardioverter Defibrillator Manufacturers
14. Assessment Of End Users Of Wearable Cardioverter Defibrillator
15. Growth Opportunity Analysis For Business Development
16. Analysis On The Wearable Cardioverter Defibrillator Ecosystem
17. Competitive Structure
O Competitive Benchmarking
O Detailed Overview
O Assessment Of Key Product Offerings
O Analysis Of Growth Strategies
O Exhaustive Analysis On Key Financial Indicators
O Swot Analysis
O Market Share Analysis Of Leading Companies In Wearable Cardioverter Defibrillator Market
O Company Assessment For Players Operating In The Market
> Zoll Medical Corporation
O Company Assessment For Players With Product In Pipeline
> Kestra Medical Technologies, Inc.
> Element Science
> Medtronic
> General Electric
18. Global Wearable Cardioverter Defibrillator Market Outlook
> By Value (USD Million)
Global Wearable Cardioverter Defibrillator Market Segmentation Analysis, 2019-2028
> By Indication
- Peripartum Cardiomyopathy, 2019-2028f (USD Thousand)
- Congenital Heart Disease, 2019-2028f (USD Thousand)
- Ventricular Arrhythmias, 2019-2028f (USD Thousand)
- Tetralogy Or Fallot, 2019-2028f (USD Thousand)
- Myocardial Infarction, 2019-2028f (USD Thousand)
- Wolff-Parkinson White Syndrome, 2019-2028f (USD Thousand)
- Others, 2019-2028f (USD Thousand)
> By Demography
- Pediatric, 2019-2028f (USD Thousand)
- Adults, 2019-2028f (USD Thousand)
- Geriatric, 2019-2028f (USD Thousand)
> By End User
- Hospitals, 2019-2028f (USD Thousand)
- Home Care Settings, 2019-2028f (USD Thousand)
- Cardiology Clinics, 2019-2028f (USD Thousand)
> By Region
- Asia Pacific, 2019-2028f (USD Thousand)
- North America, 2019-2028f (USD Thousand)
- Latin America, 2019-2028f (USD Thousand)
- Europe, 2019-2028f (USD Thousand)
- Middle East & Africa, 2019-2028f (USD Thousand)
19. North America Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
19.1. Market Overview
19.2. Market Size, 2019-2028f (USD Thousand)
19.3. Assessment Of Macroeconomic Factors
19.4. Analysis Of Leading Companies
19.5. Market Segmentation
> By Indication
> By Demography
> By End User
> By Country
- US, 2019-2028f (USD Thousand)
- Canada, 2019-2028f (USD Thousand)
20. Europe Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
20.1. Market Overview
20.2. Market Size, 2019-2028f (USD Thousand)
20.3. Assessment Of Macroeconomic Factors
20.4. Analysis Of Leading Companies
20.5. Market Segmentation
> By Indication
> By Demography
> By End User
> By Country
- Germany, 2019-2028f (USD Thousand)
- UK, 2019-2028f (USD Thousand)
- France, 2019-2028f (USD Thousand)
- Italy, 2019-2028f (USD Thousand)
- Spain, 2019-2028f (USD Thousand)
- Russia, 2019-2028f (USD Thousand)
- Rest Of Europe, 2019-2028f (USD Thousand)
21. Asia Pacific Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
21.1. Market Overview
21.2. Market Size, 2019-2028f (USD Thousand)
21.3. Market Segmentation
> By Indication
> By Demography
> By End User
> By Country
- China, 2019-2028f (USD Thousand)
- India, 2019-2028f (USD Thousand)
- Japan, 2019-2028f (USD Thousand)
- South Korea, 2019-2028f (USD Thousand)
- Australia, 2019-2028f (USD Thousand)
- Malaysia, 2019-2028f (USD Thousand)
- Singapore, 2019-2028f (USD Thousand)
- Vietnam, 2019-2028f (USD Thousand)
- Rest Of Asia Pacific, 2019-2028f (USD Thousand)
22. Latin America Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
22.1. Market Overview
22.2. Market Size, 2019-2028f (USD Thousand)
22.3. Assessment Of Macroeconomic Factors
22.4. Analysis Of Leading Companies
22.5. Market Segmentation
> By Indication
> By Demography
> By End User
> By Country
- Brazil, 2019-2028f (USD Thousand)
- Mexico, 2019-2028f (USD Thousand)
- Argentina, 2019-2028f (USD Thousand)
- Rest Of Latin America, 2019-2028f (USD Thousand)
23. Middle East & Africa Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
23.1. Market Overview
23.2. Market Size, 2019-2028f (USD Thousand)
23.3. Assessment Of Macroeconomic Factors
23.4. Analysis Of Leading Companies
23.5. Market Segmentation
> By Indication
> By Demography
> By End User
> By Country
- GCC, 2019-2028f (USD Thousand)
Israel, 2019-2028f (USD Thousand)
South Africa, 2019-2028f (USD Thousand)
- Rest Of Middle Eat & Africa, 2019-2028f (USD Thousand)
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation, and General Electric Company.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports